Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT00572169
What this trial is testing

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Who this might be right for
Multiple Myeloma
University of Arkansas 177
Early research (Phase 1)UnknownNCT05438394
What this trial is testing

Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 24
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)Ended earlyNCT02353572
What this trial is testing

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaPlasmacytosisRecurrent Plasma Cell Myeloma+1 more
University of Colorado, Denver 3
Large-scale testing (Phase 3)Study completedNCT01063179
What this trial is testing

Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 511
Testing effectiveness (Phase 2)Study completedNCT00112827
What this trial is testing

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaSmoldering Multiple MyelomaStage I Multiple Myeloma+2 more
City of Hope Medical Center 54
Testing effectiveness (Phase 2)UnknownNCT04897139
What this trial is testing

Flu-Bu-Mel Based Conditioning Regimen for Patients With Lymphoid Malignancies Undergoing Allo-HSCT

Who this might be right for
Lymphoid Neoplasm
Shanghai Jiao Tong University School of Medicine 23
Testing effectiveness (Phase 2)Study completedNCT00943592
What this trial is testing

Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies

Who this might be right for
Advanced Hematologic MalignanciesLeukemiaPreleukemia
University of Chicago 82
Testing effectiveness (Phase 2)Study completedNCT00961467
What this trial is testing

RMPT for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 44
Testing effectiveness (Phase 2)Study completedNCT03555032
What this trial is testing

TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion)

Who this might be right for
Melanoma and Sarcoma
Royal Marsden NHS Foundation Trust 15
Not applicableLooking for participantsNCT07662018
What this trial is testing

Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors

Who this might be right for
Prospective Observational StudyGemcitabineDocetaxel+5 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT00429026
What this trial is testing

Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Renal Cell Cancer
M.D. Anderson Cancer Center 40
Not applicableLooking for participantsNCT06125483
What this trial is testing

TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT

Who this might be right for
Hematopoietic MalignancyRelapse/RecurrenceHematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 38
Testing effectiveness (Phase 2)Ended earlyNCT01453088
What this trial is testing

Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 63
Testing effectiveness (Phase 2)UnknownNCT03570983
What this trial is testing

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion

Who this might be right for
Multiple Myeloma
Swedish Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT01274403
What this trial is testing

Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Gruppo Italiano Studio Linfomi 130
Large-scale testing (Phase 3)Study completedNCT00434161
What this trial is testing

Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Swedish Orphan Biovitrum 281
Large-scale testing (Phase 3)Not Yet RecruitingNCT06613035
What this trial is testing

Twice-per-weekSelinexor, 2 Days Melphalan

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 126
Testing effectiveness (Phase 2)Study completedNCT01702831
What this trial is testing

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

Who this might be right for
Multiple Myeloma
University Health Network, Toronto 78
Testing effectiveness (Phase 2)Ended earlyNCT00985907
What this trial is testing

Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaPatient Participation
University of California, San Francisco 13
Next Page